Literature DB >> 32276068

Cortical remodelling in childhood is associated with genes enriched for neurodevelopmental disorders.

G Ball1, J Seidlitz2, R Beare3, M L Seal4.   

Abstract

Cortical development during childhood and adolescence has been characterised in recent years using metrics derived from Magnetic Resonance Imaging (MRI). Changes in cortical thickness are greatest in the first two decades of life and recapitulate the genetic organisation of the cortex, highlighting the potential early impact of gene expression on differences in cortical architecture over the lifespan. It is important to further our understanding of the possible neurobiological mechanisms that underlie these changes as cortical thickness may be altered in several common neurodevelopmental and psychiatric disorders. In this study, we combine MRI acquired from a large typically-developing childhood population (n ​= ​768) with comprehensive human gene expression databases to test the hypothesis that disrupted mechanisms common to neurodevelopmental disorders are encoded by genes expressed early in development and nested within those associated with typical cortical remodelling in childhood. We find that differential rates of thinning across the developing cortex are associated with spatially-varying gradients of gene expression. Genes that are expressed highly in regions of accelerated thinning are expressed predominantly in cortical neurons, involved in synaptic remodelling, and associated with common cognitive and neurodevelopmental disorders. Further, we identify subsets of genes that are highly expressed in the prenatal period and jointly associated with both developmental cortical morphology and neurodevelopmental disorders.
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32276068     DOI: 10.1016/j.neuroimage.2020.116803

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  5 in total

1.  Uncovering the genetic profiles underlying the intrinsic organization of the human cerebellum.

Authors:  Yaping Wang; Lin Chai; Congying Chu; Deying Li; Chaohong Gao; Xia Wu; Zhengyi Yang; Yu Zhang; Junhai Xu; Jens Randel Nyengaard; Simon B Eickhoff; Bing Liu; Kristoffer Hougaard Madsen; Tianzi Jiang; Lingzhong Fan
Journal:  Mol Psychiatry       Date:  2022-03-09       Impact factor: 13.437

Review 2.  Imaging Genetics in Epilepsy: Current Knowledge and New Perspectives.

Authors:  Ge Wang; Wenyue Wu; Yuchen Xu; Zhuanyi Yang; Bo Xiao; Lili Long
Journal:  Front Mol Neurosci       Date:  2022-05-30       Impact factor: 6.261

3.  Mutations associated with neuropsychiatric conditions delineate functional brain connectivity dimensions contributing to autism and schizophrenia.

Authors:  Clara A Moreau; Sebastian G W Urchs; Kumar Kuldeep; Pierre Orban; Catherine Schramm; Guillaume Dumas; Aurélie Labbe; Guillaume Huguet; Elise Douard; Pierre-Olivier Quirion; Amy Lin; Leila Kushan; Stephanie Grot; David Luck; Adrianna Mendrek; Stephane Potvin; Emmanuel Stip; Thomas Bourgeron; Alan C Evans; Carrie E Bearden; Pierre Bellec; Sebastien Jacquemont
Journal:  Nat Commun       Date:  2020-10-19       Impact factor: 14.919

Review 4.  Neurodevelopment of the association cortices: Patterns, mechanisms, and implications for psychopathology.

Authors:  Valerie J Sydnor; Bart Larsen; Danielle S Bassett; Aaron Alexander-Bloch; Damien A Fair; Conor Liston; Allyson P Mackey; Michael P Milham; Adam Pines; David R Roalf; Jakob Seidlitz; Ting Xu; Armin Raznahan; Theodore D Satterthwaite
Journal:  Neuron       Date:  2021-07-15       Impact factor: 18.688

5.  Structural Connectivity Gradients of the Temporal Lobe Serve as Multiscale Axes of Brain Organization and Cortical Evolution.

Authors:  Reinder Vos de Wael; Jessica Royer; Shahin Tavakol; Yezhou Wang; Casey Paquola; Oualid Benkarim; Nicole Eichert; Sara Larivière; Ting Xu; Bratislav Misic; Jonathan Smallwood; Sofie L Valk; Boris C Bernhardt
Journal:  Cereb Cortex       Date:  2021-10-01       Impact factor: 5.357

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.